08/12/2025
6:22 PM | AbbVie (Subject)
SALEKI-GERHARDT AZITA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2025
4:03 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2025
3:40 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/04/2025
2:17 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2025
6:48 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
4:00 PM | AbbVie (Issuer)
Crum Demetris D (Reporting)
| Form 3/A | |
07/11/2025
5:20 PM | AbbVie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2025
12:20 PM | AbbVie (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
07/03/2025
12:07 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
4:04 PM | AbbVie (Issuer)
FALK THOMAS J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ABBV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter. |
05/13/2025
4:05 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Davis Jennifer L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Hart Brett J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
MEYER MELODY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Roberts Rebecca B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
TILTON GLENN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
FALK THOMAS J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
12:24 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
6:48 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
4:30 PM | AbbVie (Subject)
Stewart Jeffrey Ryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/24/2025
6:40 PM | AbbVie (Filer)
| Form ARS | |
03/24/2025
3:28 PM | AbbVie (Filer)
| Form DEF 14A | |
03/24/2025
3:28 PM | AbbVie (Filer)
| Form DEFA14A | |
03/18/2025
4:00 PM | AbbVie (Issuer)
Reents Scott T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:34 PM | AbbVie (Subject)
Reents Scott T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
4:05 PM | AbbVie (Filer)
| Form PRE 14A | |
03/10/2025
3:28 PM | AbbVie (Issuer)
Purdue David Ryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/03/2025
4:57 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:37 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:00 PM | AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:00 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:47 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
4:00 PM | AbbVie (Filer)
| Form 424B5 | |
02/19/2025
8:22 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
8:25 PM | AbbVie (Subject)
| Form FWP | |
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad) The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million.
Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant. See his full breakdown of the seven stocks to own now |
02/18/2025
7:41 AM | AbbVie (Filer)
| Form 424B5 | |
02/14/2025
12:17 PM | AbbVie (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
6:30 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
6:42 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
7:31 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:00 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:34 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
3:15 PM | AbbVie (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
3:16 PM | AbbVie (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
1:19 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:43 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:07 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:00 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:06 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
2:30 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access